EXAS earnings call for the period ending September 30, 2023.

Related Keywords

Japan , Seattle , Washington , United States , Wisconsin , Japanese , Americans , William Blair , America Merrill Lynch , Andrew Brackmann William Blair , Kevin Conroy , Dan Brennan , Mark Massaro , Megan Jones , Puneet Souda Leerink , Patrick Donnelly Citi , Vijay Kumar Evercore , Goldman Sachs , Matt Sykes Goldman Sachs , Erik Holznecht , Jeff Elliott , Dan Leonard , Brandon Couillard Jefferies , Everett Cunningham , Kyle Mikson Canaccord Genuity , European Society Of Medical Oncology Congress , Jack Meehan Nephron Research Analyst , Derik De Bruin Bank , Health Systems , Company Analyst , Jack Meehan At Nephron Research , United States Preventive Services Task , Dan Arias Stifel Financial Corp , Albert Hu Craig Hallum Capital Group Analyst , American College Of Gastroenterology Conference , Exact Sciences , Exact Science , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Resolution Biosciences , American College , Gastroenterology Conference , Precision Oncology , European Society , Medical Oncology , Financial Officer , Chief Operating , Catherine Schulte , Brandon Couillard , New Year , Derek De Bruin , Andrew Brackmann , Vijay Kumar , Res Bio , Matt Sykes , Patrick Donnelly , Jack Meehan , United States Preventive Services Task Force , Puneet Souda , Cologuard Blood , Dan Arias , Analyst Day , Kyle Mikson , Eve Burstein , Scare Gap , Alex Nowak , Hallum Capital Group , Chief Commercial , Nephron Research , Leerink Partners , Stifel Financial ,